Article
Genetically Engineered Mouse Models Unveil Mechanisms and Therapeutic Strategies for GMPPB-Associated Dystroglycanopathy
2024-08-16
Abstract excerpt
<title>Abstract</title> <p>The pathogenesis and therapeutic avenues for GDP-mannose pyrophosphorylase B (GMPPB)-associated dystroglycanopathy (DPG) have not been comprehensively characterized. Recent studies have highlighted a significant association between mutations in GMPPB with DGP, a rare disease characterized by neuromuscular phenotypes. To interrogate the molecular mechanisms driving the onset and progress...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 47303842-6eba-5d3d-875c-7abde1ab6b36
- DOI
- 10.21203/rs.3.rs-4502560/v1
